Anticoagulant drug developer Cardrenal Therapeutics files for $10M IPO

designer491 Anticoagulant drug developer Cardrenal Therapeutics (CVKD) has filed for a proposed $10M initial public offering. Cardrenal said in a filing that it considering offering 2M shares at the assumed price of $5 per share, which would raise $10M. Underwriters would be granted a 45-day option to buy up to 300K additional shares. Boustead Securities … Read more